Paul Marks Prize for Cancer Research

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

The Paul Marks Prize for Cancer Research is awarded by the Memorial Sloan Kettering Cancer Center to recognize cancer researchers who are making significant contributions to the understanding of cancer or are improving the treatment of the disease through basic or clinical research. [1][2]

The prize is awarded biennially to up to three recipients aged 45 or younger, who are selected by a panel of investigators from leading research institutions. Each presents his or her work at a scientific symposium at Memorial Sloan Kettering Cancer Center, receives a medal and shares a cash award of $150,000. The prize is named after Paul A. Marks, President Emeritus of the Memorial Sloan Kettering Cancer Center.

Prizewinners[edit]

Source: Memorial Sloan Kettering Cancer Center

See also[edit]

References[edit]

  1. ^ "Paul Marks Prize for Cancer Research". Memorial Sloan Kettering Cancer Center. Retrieved 26 November 2015.
  2. ^ "Distinguished Awards and Prizes". Harvard Medical Scholool. Retrieved 26 November 2015.
  3. ^ "Three Young Investigators Named Winners of 2015 Paul Marks Prize for Cancer Research". ASCO Post. Retrieved 26 November 2015.